Search

Novel Self-Organizing 3D Human Neuromuscular Organoids

Reference Number TO 03-00493

Keywords

organoid, neuromuscular, neuromuscular junction, SMA, ALS, myasthenia gravis, spinal muscular atrophy, muscular dystrophy, amyotrophic lateral sclerosis

Invention Novelty

Novel human neuromuscular organoids (NMOs) are provided that can be maintained in 3D culture for several months. HPSC-derived neuromesodermal progenitors (NMP) simultaneously generate spinal cord neurons and skeletal muscle cells that self-organize and generate NMO with functional neuromuscular junctions (NMJ).

Value Proposition

The capacity of organoids to generate complex three-dimensional (3D) structures resembling specific organs is transforming the field of biomedicine. While techniques for developing organoids for different single tissues, including the brain, retina, liver, and gut, have advanced in the past decade, it has remained a significant challenge to simultaneously grow two different tissues in a single functional organoid. Such complex organoids are needed to model diseases where more than one tissue is affected, such as neuromuscular diseases. These diseases are caused by functional defects of the nervous system, skeletal muscle, or arise by defects of the NMJ which is a highly organized chemical synapse formed between motor neurons and skeletal muscles. The NMOs presented here generate all  components of the NMJ simultaneously which has been a major challenge so far.

Novel Self-Organizing 3D Human Neuromuscular Organoids

Technology Description

The NMOs contain functional NMJ supported by terminal Schwann cells. They contract and develop central pattern generator-like neuronal circuits important for locomotion. As a proof of principle such NMOs have been used to model key aspects of myasthenia gravis pathology, thus highlighting the significant potential of NMOs for modeling neuromuscular diseases in the future.

Commercial Opportunity

The model is available for collaboration in drug discovery or general studies of neuromuscular diseases.

Development Status

In vitro

Patent Situation

US patent application US 63/050,736 with priority of 10.7.2020

Further Reading

Self-Organizing 3D Human Trunk Neuromuscular Organoids. Cell Stem Cell (2020), 26, 172-186.

 

DOI: 10.1016/j.stem.2019.12.007